191 related articles for article (PubMed ID: 26264917)
1. Quality assurance in the pre-analytical phase of human urine samples by (1)H NMR spectroscopy.
Budde K; Gök ÖN; Pietzner M; Meisinger C; Leitzmann M; Nauck M; Köttgen A; Friedrich N
Arch Biochem Biophys; 2016 Jan; 589():10-7. PubMed ID: 26264917
[TBL] [Abstract][Full Text] [Related]
2. Fecal and urinary NMR-based metabolomics unveil an aging signature in mice.
Calvani R; Brasili E; Praticò G; Capuani G; Tomassini A; Marini F; Sciubba F; Finamore A; Roselli M; Marzetti E; Miccheli A
Exp Gerontol; 2014 Jan; 49():5-11. PubMed ID: 24184118
[TBL] [Abstract][Full Text] [Related]
3. Experimental and analytical variation in human urine in 1H NMR spectroscopy-based metabolic phenotyping studies.
Maher AD; Zirah SF; Holmes E; Nicholson JK
Anal Chem; 2007 Jul; 79(14):5204-11. PubMed ID: 17555297
[TBL] [Abstract][Full Text] [Related]
4. High-throughput 1H NMR-based metabolic analysis of human serum and urine for large-scale epidemiological studies: validation study.
Barton RH; Nicholson JK; Elliott P; Holmes E
Int J Epidemiol; 2008 Apr; 37 Suppl 1():i31-40. PubMed ID: 18381391
[TBL] [Abstract][Full Text] [Related]
5. Gelified Biofluids for High-Resolution Magic Angle Spinning
Takis PG; Tenori L; Ravera E; Luchinat C
Anal Chem; 2017 Jan; 89(2):1054-1058. PubMed ID: 28050906
[TBL] [Abstract][Full Text] [Related]
6. Dominant components of the Thoroughbred metabolome characterised by (1) H-nuclear magnetic resonance spectroscopy: A metabolite atlas of common biofluids.
Escalona EE; Leng J; Dona AC; Merrifield CA; Holmes E; Proudman CJ; Swann JR
Equine Vet J; 2015 Nov; 47(6):721-30. PubMed ID: 25130591
[TBL] [Abstract][Full Text] [Related]
7. NMR-based metabolomic urinalysis: a rapid screening test for urinary tract infection.
Lam CW; Law CY; To KK; Cheung SK; Lee KC; Sze KH; Leung KF; Yuen KY
Clin Chim Acta; 2014 Sep; 436():217-23. PubMed ID: 24909875
[TBL] [Abstract][Full Text] [Related]
8. 1H NMR spectroscopic analysis detects metabolic disturbances in rat urine on acute exposure to heavy metal tungsten alloy based metals salt.
Tyagi R; Rana P; Gupta M; Bhatnagar D; Srivastava S; Roy R; Khushu S
Chem Biol Interact; 2014 Mar; 211():20-8. PubMed ID: 24412238
[TBL] [Abstract][Full Text] [Related]
9. Statistical total correlation spectroscopy editing of 1H NMR spectra of biofluids: application to drug metabolite profile identification and enhanced information recovery.
Sands CJ; Coen M; Maher AD; Ebbels TM; Holmes E; Lindon JC; Nicholson JK
Anal Chem; 2009 Aug; 81(15):6458-66. PubMed ID: 19580292
[TBL] [Abstract][Full Text] [Related]
10. Development of a universal metabolome-standard method for long-term LC-MS metabolome profiling and its application for bladder cancer urine-metabolite-biomarker discovery.
Peng J; Chen YT; Chen CL; Li L
Anal Chem; 2014 Jul; 86(13):6540-7. PubMed ID: 24877652
[TBL] [Abstract][Full Text] [Related]
11. Fast and accurate quantitative metabolic profiling of body fluids by nonlinear sampling of 1H–13C two-dimensional nuclear magnetic resonance spectroscopy.
Rai RK; Sinha N
Anal Chem; 2012 Nov; 84(22):10005-11. PubMed ID: 23061661
[TBL] [Abstract][Full Text] [Related]
12. Combined 1H-NMR and 1H-13C HSQC-NMR to improve urinary screening in autism spectrum disorders.
Nadal-Desbarats L; Aïdoud N; Emond P; Blasco H; Filipiak I; Sarda P; Bonnet-Brilhault F; Mavel S; Andres CR
Analyst; 2014 Jul; 139(13):3460-8. PubMed ID: 24841505
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of metabolite profiles as biomarkers for the pharmacological effects of thiazolidinediones in Type 2 diabetes mellitus patients and healthy volunteers.
van Doorn M; Vogels J; Tas A; van Hoogdalem EJ; Burggraaf J; Cohen A; van der Greef J
Br J Clin Pharmacol; 2007 May; 63(5):562-74. PubMed ID: 17488363
[TBL] [Abstract][Full Text] [Related]
14. Recommendations and Standardization of Biomarker Quantification Using NMR-Based Metabolomics with Particular Focus on Urinary Analysis.
Emwas AH; Roy R; McKay RT; Ryan D; Brennan L; Tenori L; Luchinat C; Gao X; Zeri AC; Gowda GA; Raftery D; Steinbeck C; Salek RM; Wishart DS
J Proteome Res; 2016 Feb; 15(2):360-73. PubMed ID: 26745651
[TBL] [Abstract][Full Text] [Related]
15. Urine metabolic signature of pancreatic ductal adenocarcinoma by (1)h nuclear magnetic resonance: identification, mapping, and evolution.
Napoli C; Sperandio N; Lawlor RT; Scarpa A; Molinari H; Assfalg M
J Proteome Res; 2012 Feb; 11(2):1274-83. PubMed ID: 22066465
[TBL] [Abstract][Full Text] [Related]
16. Metabolomics in newborns with intrauterine growth retardation (IUGR): urine reveals markers of metabolic syndrome.
Dessì A; Atzori L; Noto A; Visser GH; Gazzolo D; Zanardo V; Barberini L; Puddu M; Ottonello G; Atzei A; De Magistris A; Lussu M; Murgia F; Fanos V
J Matern Fetal Neonatal Med; 2011 Oct; 24 Suppl 2():35-9. PubMed ID: 21767100
[TBL] [Abstract][Full Text] [Related]
17. Solid-phase extraction and nanoflow liquid chromatography-nanoelectrospray ionization mass spectrometry for improved global urine metabolomics.
Chetwynd AJ; Abdul-Sada A; Hill EM
Anal Chem; 2015 Jan; 87(2):1158-65. PubMed ID: 25521704
[TBL] [Abstract][Full Text] [Related]
18. Non-negative Least Squares Approach to Quantification of
Kopriva I; Jerić I; Hadžija MP; Hadžija M; Lovrenčić MV
Anal Chem; 2021 Jan; 93(2):745-751. PubMed ID: 33284005
[TBL] [Abstract][Full Text] [Related]
19. Nuclear magnetic resonance metabolomic profiling of urine provides a noninvasive alternative to the identification of biomarkers associated with endometriosis.
Vicente-Muñoz S; Morcillo I; Puchades-Carrasco L; Payá V; Pellicer A; Pineda-Lucena A
Fertil Steril; 2015 Nov; 104(5):1202-9. PubMed ID: 26297644
[TBL] [Abstract][Full Text] [Related]
20. NMR metabolomics for assessment of exercise effects with mouse biofluids.
Le Moyec L; Mille-Hamard L; Triba MN; Breuneval C; Petot H; Billat VL
Anal Bioanal Chem; 2012 Aug; 404(2):593-602. PubMed ID: 22706325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
